Condition: Asthma
Interventions: Drug: dupilumab SAR231893 (REGN668); Drug: fluticasone propionate and salmeterol; Drug: budesonide and formoterol; Drug: mometasone furoate and formoterol
Sponsors: Sanofi; Regeneron Pharmaceuticals
Not yet recruiting – verified May 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days